Cell MedX Wins E.U. Trademark Application

Cell MedX Wins E.U. Trademark Application

By: Dylan Sikes – AllPennyStocks.com News

Thursday, October 17, 2019

Receiving the blessings of government officials – domestic and foreign – is important to health-care companies peddling their wares offshore. 

Thursday, Carson City, Nevada-based Cell MedX Corp. (OTC:CMXC) announced that the European Union had approved its eBalance trademark application, and issued a certificate of registration number for the trademark eBalance in the name of the Company. 

CMXC’s eBalance trademark applications filed with the Canadian Intellectual Property Office on November 14, 2017, and with the U.S. Patent and Trademark Office on December 11, 2017, continue to be under review.

Cell MedX is a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness

Its stock soared 7.5 cents, or 17.4%, to 50.5 cents, on volume just over 20,000 


Copyright © 2019 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon

Other Penny Stock Movers

Are We On The Cusp Of A New Pot Sector Rally?
Auryn Expands High-Grade Zone
Ionix Rides Financial Figures to Sharp Stock Rise
Nocopi Rockets on Q3 Figures


Back to Top